A CRISPR-based ultrasensitive assay detects attomolar concentrations of SARS-CoV-2 antibodies in clinical samples
CRISPR diagnostics are routinely used for the detecting nucleic acids, but rarely for clinically important proteins. Here, by translating a CRISPR-based DNA test into an ultrasensitive assay for antibodies, the authors achieve antibody detection from serum samples at attomolar concentrations.
Main Authors: | Yanan Tang, Turun Song, Lu Gao, Saifu Yin, Ming Ma, Yun Tan, Lijuan Wu, Yang Yang, Yanqun Wang, Tao Lin, Feng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-32371-4 |
Similar Items
-
Rapid Detection of Attomolar SARS-CoV-2 Nucleic Acids in All-Dielectric Metasurface Biosensors
by: Masanobu Iwanaga
Published: (2022-11-01) -
A DNA biosensors-based microfluidic platform for attomolar real-time detection of unamplified SARS-CoV-2 virus
by: Perrine Robin, et al.
Published: (2023-05-01) -
CRISPR/Cas12a‐loaded intelligent DNA hydrogel for universal and ultrasensitive exosome assay
by: Jie Luo, et al.
Published: (2024-04-01) -
Recombinase Polymerase Amplification Combined with Fluorescence Immunochromatography Assay for On-Site and Ultrasensitive Detection of SARS-CoV-2
by: Guangyu Wang, et al.
Published: (2022-10-01) -
NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing
by: Wei Feng, et al.
Published: (2023-11-01)